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Cellular and Molecular Mechanism Underlying Alcohol-induced 
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Abstract
Breast cancer is a leading cause of morbidity and mortality in women. Both Epidemiological and 
experimental studies indicate a positive correlation between alcohol consumption and the risk of 
breast cancer. While alcohol exposure may promote the carcinogenesis or onset of breast cancer, it 
may as well enhance the progression and aggressiveness of existing mammary tumors. Recent 
progress in this line of research suggests that alcohol exposure is associated with invasive breast 
cancer and promotes the growth and metastasis of mammary tumors. There are multiple potential 
mechanisms involved in alcohol-stimulated progression and aggressiveness of breast cancer. 
Alcohol may increase the mobility of cancer cells by inducing cytoskeleton reorganization and 
enhancing the cancer cell invasion by causing degradation and reconstruction of the extracellular 
matrix (ECM). Moreover, alcohol may promote the epithelial-mesenchymal transition (EMT), a 
hallmark of malignancy, and impair endothelial integrity, thereby increasing the dissemination of 
breast cancer cells and facilitating metastasis. Furthermore, alcohol may stimulate tumor 
angiogenesis through the activation of cytokines and chemokines which promotes tumor growth. 
Additionally, alcohol may increase the cancer stem cell population which affects neoplastic cell 
behavior, aggressiveness, and the therapeutic response. Alcohol can be metabolized in the 
mammary tissues and breast cancer cells which produces reactive oxygen species (ROS), causing 
oxidative stress. Recent studies suggest that the epidermal growth factor receptor (EGFR) family, 
particularly ErbB2 (a member of this family), is involved in alcohol-mediated tumor promotion. 
Breast cancer cells or mammary epithelial cells over-expressing ErbB2 are more sensitive to 
alcohol’s tumor promoting effects. There is considerable cross-talk between oxidative stress and 
EGFR/ErbB2 signaling. This review further discusses how the interaction between oxidative stress 
and EGFR/ErbB2 signaling contributes to the cellular and molecular events associated with breast 
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cancer aggressiveness. We also discuss the potential therapeutic approaches for cancer patients 
who drink alcoholic beverages.
Graphical abstract
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1. Introduction
Breast cancer is a leading cause of morbidity and mortality in women [1, 2]. Although the 
exact etiology of breast cancer is unclear, nutrition and life style have been considered 
important contributing factors [3, 4]. Heavy alcohol consumption has devastating health 
effects and is associated with many maladies such as infectious diseases, cancer, digestive 
diseases, diabetes, neuropsychiatric diseases, cardiovascular disease, liver and pancreatic 
disease [5]. It is now well-established that alcohol consumption is a risk factor for breast 
cancer [6–13]. Upon careful evaluation, it appears that alcohol may not only increase the 
risk, but also promote the malignancy of existing mammary tumors; that is, alcohol may 
promote both onset/carcinogenesis and progression/prognosis.
For the onset/carcinogenesis of mammary tumors, there are several potential contributing 
mechanisms. First, alcohol exposure may cause DNA damage and gene mutation. Although 
alcohol per se is not a direct carcinogen, acetaldehyde, a product of alcohol metabolism, is a 
mutagen which can form adducts with protein and DNA, inducing gene mutation, DNA 
crosslinks and chromosomal aberrations [9, 14–18]. Alcohol dehydrogenase (ADH), a key 
enzyme of alcohol metabolism, is expressed in the human breast epithelial cells; therefore 
the human mammary tissue has the capacity to metabolize alcohol [9]. Due to limited ability 
to detoxify acetaldehyde in the mammary tissue, acetaldehyde accumulates for prolonged 
periods, which enhances its toxicity [9]. It is proposed that alcohol exposure induces 
mammary carcinogenesis through the production of acetaldehyde [19]. Second, alcohol may 
promote mammary carcinogenesis by altering circulating sex hormone levels. Sex 
hormones, such as estrogen, play an important role in the etiology of breast cancer. 
Perturbed estrogen levels and increased expression and activity of estrogen receptor α (ER-
α) are identified upon chronic alcohol consumption [9, 17, 20–23]. Third, alcohol-induced 
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dysregulation of epigenetic regulation of gene expression, particularly abnormal DNA 
methylation may also contribute to mammary carcinogenesis, because epigenetic 
dysregulation is a key mechanism for tumor initiation and progression [9, 24]. Forth, alcohol 
may promote the carcinogenesis by disrupting the homeostasis of growth factors and 
nutrient status, such as IGF1 and vitamins [19, 25–27]. In addition to its carcinogenic effect, 
alcohol abuse is associated with advanced and invasive breast cancer [28–31], suggesting 
that alcohol may promote the progression of existing tumors and induce more aggressive 
phenotypes. Indeed, a number of recent experimental studies support this hypothesis and 
show that alcohol enhances the aggressiveness and malignancy of breast cancer [32–34]. 
Although alcohol-mediated carcinogenesis and progression/aggressiveness could share some 
common causes, distinct mechanisms may operate. A better understanding of these 
mechanisms is critical in developing effective therapeutic strategies for breast cancer 
patients who drink alcoholic beverages. This review will discuss the recent progress in this 
line of research.
Experimental studies clearly demonstrate that alcohol alters the behavior of breast cancer 
cells and changes them to more aggressive phenotypes. We will first review the effect of 
alcohol on cellular events and processes associated with cancer aggressiveness and 
malignancy, and then discuss the potential underlying cellular/molecular mechanisms.
2. Alcohol-induced aggressiveness of breast cancer
2.1. Alcohol promotes migration/invasion, growth and metastasis of breast cancer cells
Cancer metastasis is the spread of cancer cells to tissues and organs beyond where the tumor 
originated and the formation of new tumors. The metastatic cascade can be separated into 
three main processes: invasion, intravasation, and extravasation. The process of invasion 
involves the loss of cell-cell adhesion capacity which allows malignant tumor cells to 
dissociate from the primary tumor mass and invade the surrounding stroma. Intravasation is 
the invasion of cancer cells through the basal membrane into a blood or lymphatic vessel. 
This process enables cells to enter the circulatory system and metastasize to distant sites. 
The process of extravasation occurs when the tumor cells have arrived at the destination, 
they penetrate the endothelium and the basement membrane, forming new tumors.
Using Boyden chamber and wound healing assays, the data from our laboratory and others 
consistently show that alcohol enhances the migration of breast cancer cells [32, 33, 35–38]. 
Alcohol-induced mobility may result from the interaction with the extracellular matrix 
(EMC) and reorganization of the cytoskeleton system [38, 39]. Alcohol also increases the 
invasive potential of breast cancer cells [37, 40–42]. The increased invasion is likely 
mediated by the enhanced ability of breast cancer cells to degrade the EMC, in which matrix 
metalloproteinases (MMPs) play an important role [40, 41]. Alcohol-stimulated migration/
invasion is further demonstrated in a 3-dimension (3-D) Matrigel system [32, 33]. The 
aggressive breast cancer cells have a property to grow to scattering spheroids in the 3-D 
culture system. We show that alcohol exposure significantly increases the spreading of 
breast cancer cells in this 3-D system. More importantly, after chronic exposure to alcohol, 
less aggressive breast cancer cells are transformed into a more aggressive phenotype which 
is demonstrated by the scattering spheroids in the 3-D culture system [32, 33]. In some 
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studies, alcohol is shown to promote the growth of breast cancer cells both in vitro and in 
vivo [21–23, 43–45]. Alcohol-induced increase in the growth of breast cancer cells may 
result from either enhanced cell proliferation or promotion of survival. Animal studies 
confirm that alcohol consumption not only promotes the growth but also the metastasis of 
breast cancer cells to the lung and colon in mice [32, 33, 43, 44]. MMTV-neu transgenic 
mice are extensively used for the study of the tumorigenesis and progression of breast 
cancer. These mice express neu oncogene (homology to human ERBB2) under the 
transcriptional control of the mouse mammary tumor virus promoter/enhancer and develop 
spontaneous mammary tumors. Chronic alcohol consumption significantly promotes the 
metastasis of breast cancer cells to the lung and colon (Fig. 1) [33].
2.2. Alcohol disrupts extracellular matrix (ECM), endothelial integrity, and promotes 
epithelial- mesenchymal transition (EMT)
One of the key functions of MMPs is to degrade the ECM, a critical step for the 
intravasation and extravasation. MMPs play an important role in the malignancy of 
mammary tumors [46]. MMP2 and MMP9 are two typical collagenases secreted by tumor 
cells or stromal cells that catalyze the destruction of the surrounding ECM. It has been 
demonstrated that alcohol can promote the degradation of the ECM by activating MMPs. 
Etique et. al. [47] show that alcohol stimulates the secretion of MMP2 and MMP9 from 
breast cancer cells. In our studies, alcohol activates MMP2 in breast cancer cells by 
promoting the cleavage of the pro-enzyme and transferring to an active enzyme. Knocking 
down of MMP2 with small interference RNA or selective inhibitors partially blocks alcohol-
stimulated cell invasion [41]. Interestingly, alcohol can also stimulate the secretion and 
activation of MMP2 from stromal fibroblast cells which are a major cell type expressing 
MMP2 [40]. Moreover, the activation of fibroblast-derived MMP2 significantly contributes 
to the invasive phenotype of breast cancer induced by alcohol exposure [40]. Different from 
the report by Etique et al. [47], our studies show that alcohol selectively activates MMP2 but 
not MMP9 in mammary epithelial cells or fibroblasts [40, 41].
Another potential mechanism for alcohol promotion of cancer metastasis is to disrupt the 
endothelial integrity which facilitates the intravasation and extravasation. Alcohol-induced 
disruption of endothelial integrity is evident by the decrease of electric resistance across the 
endothelial monolayer and the appearance of an intercellular gap among endothelial cells 
[48]. The effect of alcohol is reversible once alcohol is removed. The disruption of the 
endothelial monolayer integrity was associated with an increased invasion of cancer cells 
through the endothelial monolayer. It appears the alcohol-induced disruption of endothelial 
integrity is caused by damaged adherens junctions resulting from the endocytosis of VE-
cadherin [48]. The epithelial–mesenchymal transition (EMT) is a developmental program 
but also plays an important role in cancer progression and metastasis. Studies suggest that 
alcohol can promote EMT phenotypic change and enhance aggressiveness of breast cancer. 
For example, vimentin, as a marker of mesenchymal cells or cells undergoing EMT, is 
upregulated by alcohol in breast cancer cells; conversely, E-cadherin, a hallmark for 
epithelial cells, is downregulated in breast cancer cells [49]. Other characteristics of EMT, 
such as increased expression of MMPs (MMP2, MMP7 and MMP9) and decreased 
expression of α-, β-, and γ-catenin are observed in breast cancer cells following alcohol 
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exposure [36, 41, 49]. Snail is a key regulator of EMT and alcohol increases the expression 
and phosphorylation of Snail through stimulating EGFR signaling [49]. Together, these 
results suggest that alcohol may induce the EMT in breast cancer cells.
2.3. Alcohol enhances tumor angiogenesis
Angiogenesis in tumor tissues is an essential process for cancer growth and metastasis. 
Several studies consistently show that alcohol promotes tumor angiogenesis [39, 43, 44, 50, 
51]. A number of mechanisms have been proposed for alcohol-induced angiogenesis; these 
include enhanced endothelial cell proliferation and migration, promotion of cancer/
endothelial cell interaction and alterations of tumor microenvironment. An in vitro study 
shows that alcohol can directly target endothelial cells and cause actin filament 
reorganization, resulting in enhanced migration and tube formation of endothelial cells [39]. 
Using a 3-D endothelial cell/breast cancer cell co-culture system, we show that alcohol 
significantly increases the angiogenesis in the presence of cancer cells [43, 44]. The effect of 
alcohol is likely mediated by the stimulation of vascular endothelial growth factor (VEGF) 
and monocyte chemoattractant protein-1 (MCP-1) signaling. VEGF is a key regulator of 
angiogenesis. Alcohol upregulates the expression of VEGF and its receptor Flt-1 in mice; 
inhibiting VEGF-mediated signaling partially blocks alcohol-stimulated angiogenesis and 
tumor growth [44, 51]. MCP-1, also called chemokine (CC motif) ligand 2 (CCL2), is a pro-
inflammatory chemokine, acting as a potent chemoattractant for monocytes and 
macrophages. Alcohol increases expression of MCP-1 and its receptor CCR2 in both 
mammary tumor tissues and breast cancer cells in vitro and in vivo [43]. CCR2 antagonist 
significantly inhibits alcohol-induced tumor angiogenesis and mammary tumor growth in 
mice [43].
2.4. Alcohol increases the cancer stem-like cells (CSCs) population in breast cancer cells
Breast cancers display considerable phenotypic and genetic heterogeneity. Cancer stem cells 
(CSCs), a subpopulation of cancer cells with self-renewal and differentiation capacity, play 
an important role in tumor initiation, progression, metastasis, recurrence, and therapy 
resistance [52, 53]. The recent evidence from both in vitro and in vivo studies suggests that 
alcohol may increase the CSC population in breast cancer. We show that alcohol exposure 
causes a drastic increase in the CSC population and mammosphere formation in breast 
cancer cells overexpressing ErbB2 and in MMTV-neu mice (Fig. 2) [33]. In breast cancer 
cells with low levels of ErbB2, the CSC population is relatively small. These cells are 
relatively insensitive to acute alcohol exposure. However, long term treatment of alcohol 
also significantly increases the CSC population in these cells, which is accompanied by an 
increase in cell migration/invasion, anchorage-independent colony formation and scattering 
spheroids in a 3-D Matrigel system [32]. The findings are confirmed by the animal studies 
which show that chronic alcohol exposure increases CSCs in the mammary tumors of 
MMTV-neu transgenic mice [33].
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3. Cellular and molecular mechanisms underlying alcohol-induced cancer 
aggressiveness
3.1. Role of oxidative stress in alcohol-promoted breast cancer aggressiveness
3.1.1. Alcohol-induced reactive oxygen species (ROS) and oxidative stress in 
mammary tissues and breast cancer cells—Excessive ROS accumulation and 
oxidative stress have been proposed as important mechanisms for mammary carcinogenesis 
and aggressiveness [54]. Alcohol-induced ROS and oxidative stress may be mediated by 
alcohol metabolism, damaged mitochondria, and an antioxidant response [55]. Alcohol is 
first oxidized to acetaldehyde in cytosol by alcohol dehydrogenase (ADH). Acetaldehyde is 
transported into the mitochondria and rapidly metabolized to acetate by aldehyde 
dehydrogenase 2 (ALDH2). In the mitochondria, acetate is converted to acetyl-CoA, which 
enters the citric acid cycle for ultimate oxidization. In both ADH and ALDH2 catalyzed 
reactions, NAD+, is used as an electron carrier to form NADH, which is eventually 
transported into the mitochondria for ATP production. Depending on oxygen supply and the 
demand of ATP, NADH may not be efficiently oxidized, which causes electrons to be 
diverted to form ROS, causing oxidative stress [55]. During chronic alcohol consumption or 
in tissues that lack ADH, cytochrome P450 2E1 (CYP2E1) is induced to engage in alcohol 
metabolism, which concomitantly oxidizes NADPH to generate ROS. Alternatively, alcohol 
can activate NADPH oxidase (NOX) which produces ROS [56]. Alcohol-metabolizing 
enzymes such as cytochrome CYP2E1, ADH and xanthine oxidoreductase (XOR), and NOX 
are expressed in mammary tissues and breast cancer cells, indicating alcohol can be 
metabolized in mammary tissues [57–63].
ROS mainly comprises four species including superoxide anion, hypochlorite ion, hydroxyl 
radicals, and hydrogen peroxide. They are highly active and interact with lipid, protein, and 
DNA. Using electron spin resonance (ESR), we demonstrate that alcohol is able to generate 
a whole spectrum of ROS in mammary epithelial cells and breast cancer cells [38, 64]. 
Alcohol also promotes ROS production and oxidative stress in breast cancer-associated 
stromal fibroblasts [65]. It appears that CYP2E1 is involved in alcohol-induced ROS 
production in mammary epithelial cells; the alcohol-induced ROS in turn activates the 
epidermal growth factor receptor (EGFR) [66]. Other evidence shows that alcohol exposure 
may cause oxidative stress by down-regulation of detoxification enzymes in mammary 
epithelial cells, which results in decreased clearance of ROS [67].
3.1.2.The role of ROS in alcohol-induced aggressiveness of breast cancer 
cells—ROS is involved in alcohol-stimulated migration/invasion of breast cancer cells, 
because scavenging alcohol-induced ROS production by antioxidants significantly inhibits 
alcohol-induced migration and invasion [38, 41, 64]. ROS also plays a role in alcohol-
induced MMP2 activation; antioxidants abrogate alcohol-induced MMP2 activation and 
inhibit the alcohol-stimulated invasion in mammary epithelial cells overexpressing ErbB2 
[41, 68]. It appears that ROS mediates alcohol-induced breast cancer cells/ECM interaction 
and cell mobility. Cyanidin-3-glucoside (C3G), an anthocyanin present in many vegetables 
and fruits, is a potent natural antioxidant. We show that C3G decreases alcohol-mediated cell 
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adhesion to the ECM as well as the amount of focal adhesions and the formation of 
lamellipodial protrusion [38].
It is well established that ROS promotes EMT in mammary epithelial or breast cancer cells 
through diverse mechanisms [69, 70]. It is suggested that the activation of EGFR is involved 
in alcohol-promoted EMT [49] and alcohol may activate EGFR through intracellular ROS 
accumulation [66]. However, more direct evidece is required to draw a conclusion regrading 
the role of ROS in alcohol-promoted EMT.
ROS is long known for being involved in tumor angiogenesis [54, 71–74]. It is generally 
accepted that low levels of ROS promote angiogenesis whereas high levels of ROS may have 
the opposite effect. ROS regulation of angiogenesis is mainly mediated by VEGF signaling 
[75, 76]. But ROS can also promote angiogenesis in a VEGF independent manner [77, 78]. 
We have previously shown that alcohol-induced ROS can directly promote the tube 
formation of endothelial cells [39]. We have also demonstrated that alcohol promotes 
angiogenesis in mammary tumors by stimulating MCP-1 signaling [43] and it is likely that 
alcohol-induced activation of MCP-1 is mediated by ROS [79].
In addition to promoting angiogenesis, alcohol-induced ROS may disrupt endothelial 
integrity, consequently increasing the permeability of blood vessels. We demonstrate that 
alcohol causes a reversible disruption of the endothelial barrier and an enhanced invasion of 
cancer cells through the endothelial monolayer [48]. Vascular endothelial cadherin (VE-
cadherin), a major component of endothelial adherens junctions, plays many functional roles 
in regulating endothelial barrier integrity. VE-cadherin is linked to the actin cytoskeleton 
through β- and α-catenin. The stabilization of the cadherin/catenin complex maintains 
endothelial integrity and inhibits tumor cell intravasation and extravasation. We show that 
alcohol inhibits VE-cadherin/β-catenin association and disrupts the endothelial barrier [48]. 
Since ROS can cause phosphorylation of the VE-cadherin and thereby result in disassembly 
of VE-cadherin/catenin complex and the breakdown of intercellular connections [80–82], 
the effect of alcohol on endothelial integrity may be mediated by ROS production.
3.2. Role of epidermal growth factor receptor (EGFR) family in alcohol-promoted breast 
cancer aggressiveness
3.2.1. The EGFR and ErbB2 signaling pathways in breast cancer—The EGFR 
family is comprised of four structurally similar receptors including EGFR (ErbB1 or HER1), 
ErbB2 (HER2), ErbB3 (HER3) and ErbB4 (HER4) [83, 84]. They are type I trans-
membrane kinase receptors, which upon ligand binding in the extracellular domain, undergo 
dimerization and subsequent trans-phosphorylation in the intracellular domain. EGFR and 
ErbB2 receive particular attention in the context of breast cancer etiology and therapy 
because of their frequent overexpression and hyperactivation in breast carcinomas [83]. 
Overexpression of EGFR and ErbB2 is associated with malignant breast cancers, increased 
metastasis, and poor prognosis [84–88].
EGFR is activated by a number of ligands including EGF, amphiregulin, transforming 
growth factor alpha (TGFα), neuregulin 2β, betacellulin, heparin-binding EGF-like growth 
factor, and epiregulin [84, 89]. So far there is no identified ligand for ErbB2; the activation 
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of ErbB2 is mediated through heterodimeric partners, e.g., EGFR, ErbB3 ErbB4 [85]. Upon 
activation, EGFR and ErbB2 trigger several important signaling cascades that play a key role 
in the carcinogenesis and aggressiveness of breast cancer, such as MAPK, PI3K/AKT/
mTOR, Src, JAK/STAT3, PLC-γ/PKC and GSK3β/β-catenin [84, 88, 90–93]. The activation 
of these signaling cascades frequently promotes the proliferation, migration/invasion, 
growth, and metastasis of breast cancer [84].
3.2.2. EGFR and ErbB2 signaling in alcohol-promoted aggressiveness of 
breast cancer—It has been proposed that EGFR may mediate some of alcohol’s tumor 
promoting effects [94]. Alcohol stimulates the phosphorylation of EGFR in mammary 
epithelial cells [66]. Snail, a transcriptional activator of EMT markers, is upregulated by 
alcohol in an EGFR-dependent manner [49]. Alcohol-induced migration of breast cancer 
cells is blocked by AG1478, an EGFR inhibitor [49]. Together, the evidence indicates that 
the activation of EGFR is involved in alcohol-promoted aggressiveness of breast cancer. 
There are several potential mechanisms underlying alcohol activation of EGFR; these 
include stimulation of EGFR phosphorylation by ROS, an increase in the expression of 
ligands for EGFR, and inhibition of phosphatases that regulate the dephosphorylation of 
EGFR [94].
More studies indicate the interaction between alcohol and ErbB2. Generally, there is a 
positive correlation between the expression level of ErbB2 and the sensitivity of breast 
cancer cells to alcohol-elicited migration/invasiveness. In a study we investigated the effect 
of alcohol on various breast cancer cell lines [35, 64]. For all human breast cancer cells and 
mammary epithelial cells examined, alcohol drastically increased the migration/invasion of 
cells overexpressing ErbB2, but only had a modest or little effect on cells with low ErbB2 
expression. For breast cancer and mammary epithelial cells that are less responsive to 
alcohol, artificial overexpression of ErbB2 enhances their sensitivity to alcohol and 
potentiates alcohol-stimulated cell migration/invasion [64]. Alcohol up-regulates the 
expression of ErbB2, ErbB3 and ErbB4, but not ErbB1 in human breast cancer cells (T47D) 
[35]. Heregulin β1 (ligand for ErbB3 and ErbB4) synergizes the alcohol-stimulated invasion 
of T47D [35]. Knocking down ErbB2 with an anti-sense oligonucleotide eliminates 
heregulin β1- and alcohol-promoted cell migration/invasion [35], supporting the conclusion 
that ErbB2 is involved in alcohol-stimulated migration/invasion of breast cancer cells. The 
enhanced sensitivity of breast cancer cells overexpressing ErbB2 may be mediated by 
alcohol-induced activation of ErbB2. We show that alcohol stimulates the phosphorylation 
of ErbB2 and its interaction with downstream effectors, such as cSrc and FAK (Fig. 3) [37].
In addition to migration/invasion, alcohol-induced MMP2 activation is also dependent on the 
expression of ErbB2 [41]. Both clinical and experimental data suggest that ErbB2 may 
regulate MMP production in breast cancer cells [41, 95]. The activation of ErbB2 signaling 
increases MMP2 and MMP9 production through p38 MAPK and PI3K pathways [41]. 
Alcohol drastically activates MMP2 in mammary epithelial cells that over-express ErbB2, 
but has little effect on cells with low ErbB2 expression [41]. Furthermore, alcohol-induced 
interaction of breast cancer cells with the ECM, such as cell adhesion to the fibronectin, is 
also likely mediated by ErbB2 [37, 38]. The in vitro observation is supported by animal 
studies which show that chronic alcohol consumption enhances ErbB2 signaling in MMTV-
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neu mice and promotes the metastasis of breast cancer cells to the lung and colon (Fig 1) 
[33]. In addition, one study investigates the effect of prenatal alcohol exposure on the 
development of mammary glands and tumorigenesis in MMTV-neu mice. The results 
indicate that prenatal alcohol exposure alters the development of mammary glands and 
increases multiplicity of breast tumors with high expression of neu (ERBB2) [96].
ErbB2 also plays an important role in the alcohol-induced increase of CSC populations [33]. 
Alcohol exposure causes a drastic increase in the CSC population and mammosphere 
formation in breast cancer cells overexpressing ErbB2, but it has a modest effect on breast 
cancer cells expressing low levels of ErbB2 [33]. Consistently, alcohol consumption 
increases the CSC population and ErbB2 phosphorylation in the mammary tumors of 
MMTV-neu mice [33]. Both in vitro and in vivo studies indicate that alcohol significantly 
increases the phosphorylation of ErbB2 in breast cancer cells and mammary epithelial cells 
expressing high levels of ErbB2, but has little effect on cells with low levels of ErbB2 [33, 
37, 64]. Together, these studies confirm the idea that alcohol induces ErbB2 activation and 
results in more aggressive neoplastic behavior.
3.2.3. Down-stream signaling of EGFR and ErbB2 in alcohol-induced 
aggressiveness of breast cancer—As discussed above, a number of signaling 
cascades down-stream of EGFR and ErbB2 may be involved in alcohol-induced 
aggressiveness of breast cancer, such as MAPK, PI3K/AKT/mTOR, Src, JAK/STAT3, PLC-
γ/PKC and GSK3β/β-catenin. Alcohol activates three members of MAPKs, namely, 
extracellular signal regulated kinase (ERK), c-Jun NH2 terminal protein kinase (JNK1/2) 
and p38 mitogen-activated protein kinase (p38 MAPK) in an ErbB2-dependent manner [64]. 
Only the selective inhibitors for JNK1/2 and p38 MAPK but not for PI3K and ERK inhibits 
alcohol-induced migration/invasion of breast cancer cells overexpressing ErbB2, indicating 
that JNK1/2 and p38 MAPK are involved in alcohol-promoted aggressiveness [64].
To further analyze the contribution of p38 MAPK to alcohol-promoted aggressiveness of 
breast cancer, we examined the effect of alcohol on p38 MAPK isoforms. So far, there are 
four p38 MAPK isoforms, p38α, p38β, p38γ and p38δ. We show that alcohol selectively 
activates p38γ but not other isoforms in an ErbB2-dependent manner [32]. p38γ is 
particularly implicated in breast cancer progression and aggressiveness [97]. We show that 
p38γ is down-stream of ErbB2 because inhibition of ErbB2 abolishes alcohol-induced 
activation of p38γ and its interaction with the substrate, SAP97/DLG. SAP97/DLG is a 
scaffold protein and is involved in cell migration [98, 99]. Moreover, the activation of 
ErbB2/p38γ/SAP97/DLG axis appears to mediate an alcohol-induced increase in migration/
invasion as well as CSC because blocking ErbB2 or p38γ significantly inhibits alcohol-
stimulated migration/invasion and increases CSC population [32].
RhoC, a member of Rho family of GTPase, has been suggested to enhance cell mobility and 
metastasis through the degradation and reconstruction of the ECM and induction of 
angiogenic factors [100–102]. Our results show that RhoC is a downstream effector of 
ErbB2 and p38γ. The alcohol-induced activation of p38γ upregulates RhoC levels by 
promoting RhoC stability which results in enhanced migration/invasion [32].
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FAK is a component of focal adhesions and regulates the formation of the focal complex. 
ErbB2/ErbB3 signaling has been reported to activate FAK, which leads to oncogenesis and 
invasiveness of breast cancer [103]. In addition, it has been suggested that FAK may regulate 
the activity of p38 MAPK and JNKs [104, 105]. We show that alcohol-induced activation of 
ErbB2 causes the phosphorylation of FAK (Y861) and cSrc (Y216), and promotes the 
interaction among them in breast cancer cells overexpressing ErbB2 (Fig. 3) [37]. 
Functionally, active FAK promotes cell adhesion to fibronectin, an important component of 
the ECM. AG825, an inhibitor for ErbB2, inhibits ErbB2 phosphorylation and its association 
with FAK, blocking alcohol-promoted formation of focal adhesions [37].
GSK3β/β-catenin pathway plays an important role in tumorigenesis and cancer therapy 
[106]. We show that alcohol activates this pathway by inhibiting GSK3β, which results in an 
increase in the migration/invasion of colon cancer cells [107]. However, the effect of alcohol 
on the GSK3β/β-catenin pathway in the context of breast cancer aggressiveness needs to be 
further verified.
3.3. The interaction between ROS and EGFR/ErbB2 signaling pathway in response to 
alcohol exposure
As discussed above, both oxidative stress and EGFR/ErbB2-mediated cell signaling play an 
important role in alcohol-promoted aggressiveness of breast cancer. There is considerable 
interaction between oxidative stress and EGFR/ErbB2. ROS may either activate EGFR/
ErbB2 or directly target their down-stream signaling components [108–110]. This is 
supported by the evidence showing that alcohol stimulates the phosphorylation of EGFR and 
ErbB2 in mammary epithelial cells and breast cancer cells in a ROS-dependent manner [38, 
66]. Cyanidin-3-glucoside (C3G), a potent antioxidant scavenges alcohol-induced ROS 
accumulation, blocks alcohol-induced phosphorylation of ErbB2 and the activation of down-
stream signaling proteins, such as cSrc, FAK and p130Cas [38]. We further demonstrate that 
alcohol-induced ROS may activate MMP2 through the conventional PKC pathway in 
fibroblasts, which promotes the migration/invasion of breast cancer cells [40].
On the other hand, the status of EGFR/ErbB2 may also contribute to alcohol-induced 
oxidative stress. For example, it appears that high levels of ErbB2 make breast cancer cells 
and mammary epithelial cells more susceptible to alcohol-stimulated production of ROS 
[64]. In ErbB2 over-expressed cells, alcohol causes more intracellular accumulation of •OH 
radicals than in cells with low ErbB2 levels. The high levels of ROS in turn activates ErbB2-
mediated signaling as well as enzymes that contribute to aggressive behaviors of breast 
cancer cells, such as p38γ, FAK, and MMP-2. The mechanisms underlying how ErbB2 
contribute to alcohol-induced ROS production remain unclear.
4 Conclusion, potential therapeutic targets, and future studies
The experimental studies support the epidemiological observations that alcohol enhances the 
aggressiveness of breast cancer. However, the underlying mechanisms are complex and 
likely involved in multiple factors. Available evidence clearly demonstrates that ROS and 
EGFR/ErbB2 signaling play an important role in this process. Therefore, the approaches 
targeting oxidative stress and EGFR/ErbB2 signaling should be preferentially considered. 
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First, scavenging alcohol-induced ROS using natural antioxidants is a practical strategy. For 
example, C3G, a potent natural antioxidant rich in many vegetables and fruits, proves to be 
very effective in alleviating alcohol-induced oxidative stress in breast cancer cells and 
neurons while it has a low cytotoxicity [38, 111]. C3G has been proved to significantly 
attenuate alcohol-induced phosphorylation of ErbB2 and migration/invasion of breast cancer 
cells. Second, breast cancer cells with high levels of EGFR/ErbB2 appear to be more 
sensitive to alcohol. A further analysis of clinical data is necessary to establish the 
association of EGFR/ErbB2 status and the aggressiveness of breast cancer in the context of 
alcohol consumption. Reagents targeting these receptors, such as erlotinib (Tarceva) and 
trastuzumab (Herceptin), should be considered in patients who drink alcoholic beverages. 
Since alcohol specifically affects some signaling components and enzymes, such as p38γ 
and MMP2, drugs targeting these proteins may alleviate the aggressive behaviors associated 
with alcohol consumption. For example, selective inhibition of p38γ is sufficient to 
attenuate alcohol-stimulated CSC in breast cancer [33]. The inhibitors targeting MMP2 is 
also effective in blocking alcohol-stimulated invasion of breast cancer cells [41]. Third, 
targeting alcohol-promoted tumor angiogenesis may also be an important approach. For 
example, the growth factor VEGF and chemokine MCP-1 is involved in alcohol-promoted 
tumor angiogenesis [43, 44]; blocking VEGF and MCP-1-mediated signaling inhibits 
alcohol-induced tumor angiogenesis, growth and metastasis of breast cancer cells. Since 
alcohol affects multi-components/cascades involved in tumor progression and 
aggressiveness, future experimental studies may need to simultaneously target multiple 
components or cascades, which will likely yield more effective therapeutic outcomes 
particularly for alcoholic cancer patients. Finally, owing to the evidence that alcohol 
increases breast cancer progression, primary care givers should question each breast cancer 
patient about her alcohol intake. If the consumption is determined excessive, the patient 
should be informed about its consequences and recommend that alcohol intake be prohibited 
or reduced.
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Figure 1. 
Alcohol promotes cancer metastasis and the activation of ErbB2. A: FVB MMTV Neu mice 
were fed with liquid diet containing ethanol (0 or 6.7%). After tumors reached a maximal 
diameter of 20 mm, mice were sacrificed and analyzed for tumor metastasis. Alcohol 
consumption significantly increased the metastases in the lung and colon. B: After alcohol 
exposure, the mammary tumor tissues were assessed for the expression of phosphorylated 
ErbB2 (pErbB2) and p38γ MAPK (p-p38γ) by immunoblotting. The relative levels of 
pErbB2 and p-p38γ were quantified and normalized to the loading control. * denotes 
significant difference from control groups (p < 0.05). Alcohol consumption significantly 
increased the phosphorylation of ErbB2 and p38γ ([33].
Wang et al. Page 19
Pharmacol Res. Author manuscript; available in PMC 2018 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. 
Alcohol increases the cancer stem-like cell (CSC) population. A: Human breast cancer cell 
lines MCF7 or MCF7 overexpressing ErbB2 cells (MCF7-ErbB2) were exposed to alcohol 
(0 or 100 mg/dl) for 10 days, and then evaluated for CSCs by the ALDEFLUOR assay. * 
denotes significant difference from respective control groups. # denotes significant 
difference from alcohol-treated MCF7 cells. B: MCF7-ErbB2 cells were exposed to alcohol 
(0, 100 mg/dl) for 10 days and then mammosphere formation was evaluated under the 
microscope. C: MCF7, MCF7-ErbB2 or BT474 cells were exposed to alcohol (0, 100 
mg/dl) for 10 days. The number of mammospheres was determined. * denotes significant 
difference from respective control groups. # denotes significant difference from alcohol-
treated MCF7 cells. D: FVB MMTV Neu mice were fed with a liquid diet containing 
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ethanol (0 or 6.7%). After alcohol exposure, the mammary tumor tissues were assessed for 
the expression of CD44. * denotes significant difference from respective control groups. 
Alcohol significantly increased CSC population in vitro and in vivo [33].
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Figure 3. 
Alcohol stimulates the phosphorylation of ErbB2, FAK and cSrc. A: MCF7-ErbB2 cells 
were pretreated with alcohol for 48 hours and plated to fibronectin-coated coverslips, 
allowing attachment for 1 hour. Phosphorylation of FAK (Tyr861) and ErbB2 (Tyr1248) was 
detected with immunofluorescent staining. Arrows indicate the co-localization of pErbB2 
and pFAK. B: MCF7-ErbB2 cells were pretreated with alcohol for 6–48 hours, and allowed 
to attach for 3 hours. Cell lysates were collected and analyzed for the phosphorylation of 
FAK and cSrc with immunoblotting. The relative levels of pFAK and pcSrc were quantified 
and normalized to the expression of FAK and cSrc, respectively. * denotes significant 
difference from respective control groups. Alcohol significantly increased the 
phosphorylation of ErbB2, FAK and cSrc [37].
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